Article
Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
Antiviral therapy - 1 Jan 2018
Oh Ding Yuan, Panozzo Jacqueline, Vitesnik Sophie, Farrukee Rubaiyea, Piedrafita David, Mosse Jennifer, Hurt Aeron C
Abstract excerpt
BACKGROUND: Intravenous zanamivir has been used to treat patients with severe influenza. Because the majority of cases (including immunocompromised patients) require the drug for an extended period of treatment, there is a higher risk that the virus will develop resistance. Therefore, knowing the possible amino acid substitutions that may arise in recently circulating influenza strains under prolonged zanamivir...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
